Newborn Screening for Critical Congenital Heart Defects by Pulse Oximetry Fall CME Course 2012 Robert Jansen, MD St. Vincent Women’s Hospital.

Slides:



Advertisements
Similar presentations
CONGENITAL HEART DISEASE.
Advertisements

Considerations for the Neonate Delivered at Home Susan J Dulkerian, MD Director of Nurseries, Mercy Medical Center Fetus and Newborn Subcommitee Chair.
Cyanotic Congenital Heart Disease
Variability in the Delivery Room Management of Infants with Congenital Anomalies Heather M. French, MD Perelman School of Medicine at the University of.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Potential Impact of CCHD Screening Peterson C, Ailes E, Riehle-Colarusso T, et al.
Congenital Heart Disease Cheston M. Berlin, Jr., M.D. Department of Pediatrics.
Congenital Heart Disease in Neonates EGM Hoosen Paediatric Cardiology Inkosi Albert Luthuli Central Hospital.
Newborn Screening for Critical Congenital Heart Diseases (CCHD) Lazaros Kochilas, MD Associate Professor of Pediatrics University of Minnesota.
Invasive test results CHD Astraia-search CHD Q-diagnoses CHD* * CHD=structural congenital heart disease ** Right aortic arch, persistent arterial duct.
Pulse Oximetry Screening in the Asymptomatic Newborn: Science, Politics and Media Ashish B. Shah MD, MBA Arizona Pediatric Cardiology Consultants Lancaster.
Newborn Screening for Critical Congenital Heart Disease
Early Hearing Detection and Intervention (EHDI) ~ Challenges and Opportunities ~
Bob Bowman, MS Director of Genomics & Newborn Screening Indiana State Department of Health.
Screening for Critical Congenital Heart Disease using Pulse Oximetry Legislative Advocacy Anoop Rao PGY2, Pediatrics Image
Cyanotic congenital heart disease Case Presentation Term male infant delivered by spontaneous vaginal delivery and appears cyanotic at birth respiratory.
Congenital Heart Disease Seth Malin, MD Bronson Methodist Hospital MSU KCMS, College of Human Medicine.
PATENT DUCTUS ARTERIOSUS By: Nicole Stevens. Patent Ductus Arteriosus is a functional connection between the pulmonary artery and the descending aorta.
A Quick Tour of Congenital Heart Disease
John R. Phillips, M.D. Associate Professor of Pediatrics
HOW TO DEAL WITH A NEWBORN BABY WITH CONGENITAL HEART DISEASE ?
Postmortem examination of human fetal hearts at or below 20 weeks’ gestation: a comparison of high-field MRI at 9.4 T with lower-field MRI magnets and.
Congenital Heart Defects
Pulse oximetry screening for congenital heart disease. Does it work? Is it worth it?
Critical Congenital Heart Disease Screening Saving Lives One Infant at a Time Christina Rust, MSN, RN.
Congenital Heart Lesions. Outline Normal anatomy L -> R shunt Left side obstruction Cyanotic heart lesions Right side obstruction and R -> L shunt Transposition.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 40 Nursing Care of the Child with a Cardiovascular Disorder.
CONGENITAL DISEASES Dr. Meg-angela Christi Amores.
2014 Summit Co-Convener:Founder: Patient Safety Science & Technology Summit 2014.
Alterations of Cardiovascular Function in Children
Congenital Heart Disease Emad Al Khatib, RN,MSN,CNS.
INTRODUCTION The Normal Heart has four chambers. Consisting of the 2 basic circulation; The pulmonary circulation carrying the deoxygenated blood and.
INTRODUCTION A 35 year old woman with transposition of the great arteries repaired with a Mustard procedure attends your clinic for annual follow-up. Her.
Screening for Critical Congenital Heart Disease in Newborns Using Pulse Oximetry – New Jersey’s Experience Lori Freed Garg, MD, MPH New Jersey Department.
Pulse Oximetry screening for Cardiac malformations in the neonate Majd Abu-Harb September 2014.
Prepared by Dr Nahed El- nagger Assistant professor of Nursing
DUCTAL STENTING THROUGH LEFT INTERNAL CAROTID ARTERY IN A 5 YEAR OLD MALE WITH PULMONARY VALVE ATRESIA: A CASE REPORT Bee Jane T. Martinez, MD UP-PGH Department.
Ebstein’s anomaly Polina Petrovic July Definition Congenital cardiac malformation characterized by apical displacement of septal and posterior tricuspid.
Bob Bowman, MS Director of Genomics & Newborn Screening Indiana State Department of Health.
Congenital Heart Disease in Children Dr. Sara Mitchell January
CYANOTIC CONGENITAL HEART DISEASE
Vanessa Beretta & Dan Fleming. About CHD A congenital heart defect also known as CHD is a defect in the structure of the heart and great vessels. Most.
Congenital Heart Disease Most occur during weeks 3 to 8 Incidence 6 to 8 per 1,000 live born births Some genetic – Trisomies 13, 15, 18, & 21 and Turner.
Congenital Heart Lesions
© The Children's Mercy Hospital, /14 Critical Congenital Heart Disease (CCHD) Meagan Dorton, MSN, MBA, RN-CPN Pulse Oximetry Screening for Detecting.
I have no relevant financial relationships with the manufacturers of any commercial products and/or provider of commercial services discussed in this CME.
DR AFTAB YUNUS FRCSEd. CHAIRMAN CARDIAC SURGERY
Lecture II Congenital Heart Diseases Dr. Aya M. Serry 2015/2016.
C ASE REPORT FOR V. GRADE STUDENTS Cardiology Dr. Kemény Viktória.
CONGENITAL HEART DISEASES
Disorders of cardiovascular function. R Pulmonary Artery.
Dr David Roden Neonatologist Staffordshire, Shropshire and Black Country Newborn Network.
Pulse Oximetry Screening for Critical Congenital Heart Disease (CCHD): The Wisconsin Experience Region IV Genetics Meeting September 11, 2012 Sharon Fleischfresser.
Chris Burke, MD. What is the Ductus Arteriosus? Ductus Arteriosus  Allows blood from RV to bypass fetal lungs  Between the main PA (or proximal left.
Why? 1 in 100 newborns have congenital heart defects 25% of all CHD are critical (CCHD) requiring intervention in the.
Congenital Heart Diseases Dr. Usha Singh Department of Pediatrics.
Congenital Heart Disease in South Texas Nadine Aldahhan, D.O.; Cherie Johnson, M.D., FACOG, MMM; Priscilla Gutierrez, RDMS, RDCS, RVT Christus Spohn Family.
Congenital Heart Disease
Telephonic survey of the use of pulse oximetry as part of routine baby checks S Goyal, S Sen.
"Fetal Diagnosis and Treatment of Cardiovascular Conditions" Shanthi Sivanandam, MD,FASE Medical Director, Fetal Cardiology Co- Director, Echocardiography.
Screening for Critical Congenital Heart Defects with pulse oximetry:
The cardiovascular system
Lorraine Freed Garg, MD, MPH Consultant in Public Health
Disclaimer The Canadian Cardiovascular Society (CCS) welcomes reuse of our educational slide deck for medical institution internal education or training.
Congenital Heart Disease
Congenital Heart Diseases
Cardiac Manifestation of DiGeorge Syndrome
CYANOTIC CONGENITAL HEART DISEASE
Factors that Influence Hospital Screening Programs
Levine RA, DO. Miladinovic B, PhD. Nardell K, MD. Galas J, MD
Gerard R. Martin, MD Medical Director, Global Services
Presentation transcript:

Newborn Screening for Critical Congenital Heart Defects by Pulse Oximetry Fall CME Course 2012 Robert Jansen, MD St. Vincent Women’s Hospital

Disclosures I have no financial relationships to disclose I will not discuss off label use or unapproved or investigational use of products or devices

Indiana Senate Bill 0552 Passed February 2011 “Cora’s Law” Per , effective January 1, 2012, all birthing facilities in Indiana will be required to perform pulse oximetry screening on all newborns to detect critical congenital heart defects (CCHDs).

Perspective on Importance In the United States: ♥ Nearly 40,000 infants/year with CHD ♥ 4,800 infants/year with CCHD ♥ Estimated as many as 200 infants/year die due to unrecognized CCHD ♥ Median age for these deaths is < 2 weeks

Critical Congenital Heart Disease ♥ Outflow tract defects – Tetralogy of Fallot – D-Transposition of the Great Vessels – Truncus Arteriosus – Total Anomalous Pulmonary Venous Return ♥ Right –sided obstructive defects – Tricuspid atresia – Pulmonary atresia, intact septum ♥ Left-sided obstructive defects – Hypoplastic left heart

Transitional Circulation ♥ Circulatory changes include: ♥ Increase in systemic vascular resistance ♥ Decrease in pulmonary vascular resistance ♥ Increase in left atrial pressure ♥ Closure of the ductus arteriosus and foramen ovale ♥ Increase in left ventricular stroke volume

Perspective on Importance: Timing of Diagnosis of CCHD

Endorsement of CCHD Screening  CCHD screening endorsed by HHS Secretary Kathleen Sibelius September, 2011  AHA, ACC, AAP, and March of Dimes all endorse CCHD screening

US CCHD Screening by States 9/2012

Screening Principles

Incidence of Congenital Heart Disease ♥ According to the March of Dimes, CHD is the most common birth defect ♥ 8/1000 babies are born with CHD – 11.6/10,000 have one of the 7 CCHDs ♥ 4/1000 require treatment within the first year of life

CHD: Morbidity and Mortality ♥ Failure to diagnose CCHD may lead to critical events, cardiogenic shock or death ♥ Neurological outcome poor with late diagnosis

Prenatal Diagnosis of CCHD ♥ Prenatal Ultrasound – Usually provides a four-chamber view of the fetal heart – Variable in quality – Detect 15% (AR)-23% (CA), to possibly 50% (estimate of best capability) of CCHDs

Detection of CHD by Physical Exam ♥ 44% of CHD detected by PE alone (Wren, Arch Dis Child Fetal Neonatal Ed 80:1999) ♥ 1/12 with murmur heard in the first day of life have CHD (Nadas’ Pediatic Cardiology) ♥ Findings associated with CCHD may not be present in the nursery

The Cyanotic “Blind Spot” JS Hokanson, Neonatology Today, Dec. 2010

Reliability of Pulse Oximetry Screening for CCHD ♥ Meta-analysis of13 eligible studies with data for 229,421 newborn babies ♥ Overall sensitivity of pulse oximetry for detection of critical congenital heart defects was 76·5% (95% CI 67·7—83·5) ♥ Specificity was 99·9% (95% CI 99·7—99·9) ♥ False-positive rate of 0·14% (95% CI 0·06— 0·33) Thangaratinam et al. The Lancet, Early Online Publication, 2 May 2012 doi: /S (12)60107-X

Reliability of Pulse Oximetry Screening for CCHD ♥ The false-positive rate for detection of critical congenital heart defects was particularly low when newborn pulse oximetry was done after 24 h from birth compared to being done before 24 h (0·05% [0·02—0·12] vs 0·50 [0·29—0·86]; p=0·0017). Thangaratinam et al. The Lancet, Early Online Publication, 2 May 2012 doi: /S (12)60107-X

Feasibility of implementing pulse oximetry screening for congenital heart disease in a community hospital ♥ From January 2009 through May 2010, of 6841 eligible newborns, 6745 newborns (98.6%) were screened. ♥ Of the nine infants with positive pulse oximetry screens: – one had CCHD – four had CHD – four others were determined to have false positive screens ♥ Average screening time was 3.5 min (0 to 35 min). Bradshaw et al Journal of Perinatology advance online publication 26 January 2012; doi: /jp

Barriers to Screening ♥ Barriers identified for a total of 166 of the 6841 enrolled newborns eligible for screening (2.4%). – screening equipment (53.6% of the time) Did not work Problems with probe placement – staff (22.9%) Too busy – infant (19.9%) Infant crying or very active – family (3.6%) Mom was in a rush – In 100% of cases where the barrier was staff-related, the infant was ultimately not screened.

Barriers to Screening ♥ Time required to overcome barriers was documented in 34 infants successfully screened and averaged 5.1 min per infant (2 to 10 min).

Costs of Screening ♥ Pulse oximeter probe ~ $30 ♥ Staff time – Doing screens – Reporting requirements ♥ “Down-stream” costs for failed screens – Echocardiograms – Transport

Performing Pulse Oximetry Screening

Screening in Your Nursery ♥ Pair screening with other standard-of-care newborn screening ♥ Consider conducting screening in a quiet area with parents present ♥ Conduct screening while the infant is awake and quiet ♥ Do not attempt pulse oximetry screening on an infant who is crying or cold

Indiana Legislative Action Infants who are in the NICU should receive pulse oximetry screening or an echocardiogram prior to discharge in order to be compliant with Indiana’s newborn screening law. All birthing facilities with NICUs are responsible for developing protocols in order to ensure that EVERY baby in the NICU is screened for CCHD. The heelstick card itself will be modified in 2012 to include pulse oximetry data. Until that time, only children who fail or do not receive pulse oximetry newborn screening need to be reported to ISDH as part of the Pulse Oximetry Monthly Summary Report.

The infant who fails the screening ♥ IF INFANT SYMPTOMATIC, TRANSFER TO NICU ♥ IF ECHO ABNORMAL, REFER TO NICU/PEDIATRIC CARDIOLOGY ♥ IF ECHO NORMAL AND INFANT ASYMPTOMATIC, CLINICAL ASSESSMENT/CONSULT WITH NEONATOLOGIST

Important Note ♥ Passing the newborn pulse oximetry screening does not rule out all important congenital heart disease – The 1 week old infant in your office still may have congenital heart disease

Findings at 1 Week Check Up ♥ In the 1 st week of life concern for cardiac disease (tachypnea, cyanosis, poor pulses) requires immediate evaluation Because of the potential for a duct-dependent lesion

Online Resources CDC – HDscreening.html HDscreening.html Children’s National Medical Center – Congenital Heart Public Health Consortium – Indiana State Department of Health –